Fair Value

12 Months Ended

Oct. 02, 2026

Fair Value Disclosures [Abstract]

FAIR VALUE

4.    FAIR VALUE

Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis

The Company measures certain assets and liabilities at fair value on a recurring basis such as its financial instruments. There have been no transfers between Level 1, 2, or 3 assets or liabilities during fiscal 2026.

Assets and liabilities recorded at fair value on a recurring basis consisted of the following (in millions):

	As of
	October 2, 2026								October 3, 2025
			Fair Value Measurements								Fair Value Measurements
	Total		Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3
Assets
Cash and cash equivalents (1)	$	2,606.1	$	2,606.1	$	—	$	—	$	1,161.3	$	1,120.3	$	41.0	$	—
U.S. Treasury and government securities	—		—		—		—		126.6		109.1		17.5		—
Corporate bonds and notes	—		—		—		—		100.5		—		100.5		—
Non-qualified deferred compensation	0.7		0.7		—		—		—		—		—		—
Total assets at fair value	$	2,606.8	$	2,606.8	$	—	$	—	$	1,388.4	$	1,229.4	$	159.0	$	—

(1) Cash equivalents included in Level 1 consist of money market funds purchased with ninety days or less until maturity.

Assets Measured and Recorded at Fair Value on a Nonrecurring Basis

The Company’s non-financial assets and liabilities, such as goodwill, intangible assets, and other long-lived assets resulting from business combinations, are measured at fair value using income approach valuation methodologies at the date of acquisition and are subsequently re-measured if there are indicators of impairment. During fiscal 2026, the Company recorded impairment charges of $66.2 million primarily related to excess supplies of $37.7 million in other current assets, certain assets held for sale of $25.7 million, and the abandonment or delay of previously capitalized in-process research and development (“IPR&D”) projects of $2.8 million, recorded within restructuring, impairment, and other charges. There were no indicators of impairment identified during fiscal 2025. During fiscal 2024, the Company recorded impairment charges of $147.9 million primarily related to the abandonment or delay of previously capitalized IPR&D projects recorded within restructuring, impairment, and other charges.

Fair Value of Debt

The Company’s debt is carried at amortized cost and is measured at fair value quarterly for disclosure purposes. The estimated fair values are based on Level 2 inputs as the fair value is based on quoted prices for the Company’s debt and comparable instruments in inactive markets.

The carrying amount and estimated fair value of debt consists of the following (in millions):

	As of
	October 2, 2026				October 3, 2025
	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
1.80% Senior Notes due 2026	$	—	$	—	$	499.4	$	491.1
5.00% Senior Notes due 2028	794.2		790.6		—		—
3.00% Senior Notes due 2031	497.0		438.5		496.4		453.4
5.75% Senior Notes due 2032	594.7		583.8		—		—
6.25% Senior Notes due 2036	586.9		572.3		—		—
Total debt under Senior Notes	$	2,472.8	$	2,385.2	$	995.8	$	944.5